Glycogen synthase kinase‐3 inhibition reduces ischemic cerebral damage, restores impaired mitochondrial biogenesis and prevents ROS production
- 28 January 2011
- journal article
- Published by Wiley in Journal of Neurochemistry
- Vol. 116 (6) , 1148-1159
Abstract
J. Neurochem. (2011) 116, 1148–1159. This study was designed to test the hypothesis that improved mitochondrial biogenesis could help reducing ischemic cerebral injury. We found that levels of proliferator‐activated receptor γ coactivator 1α and nuclear respiratory factor‐1, mitochondrial DNA content and other markers of mitochondrial biogenesis and function were reduced in primary mouse cortical neurons under oxygen‐glucose deprivation (OGD). The glycogen synthase kinase‐3 (GSK‐3) inhibitor SB216763 activated an efficient mitochondrial biogenesis program in control cortical neurons and counteracted the OGD‐mediated mitochondrial biogenesis impairment. This was accompanied by the activation of an antioxidant response that reduced mitochondrial reactive oxygen species generation and ischemic neuronal damage. The in vitro effects of SB216763 were mimicked by two other structurally unrelated GSK‐3 inhibitors. The protective effects of SB216763 on OGD‐mediated neuronal damage were abolished in the presence of diverse mitochondrial inhibitors. Finally, when systemically administered in vivo, SB216763 reduced the infarct size and recovered the loss of mitochondrial DNA in mice subjected to permanent middle cerebral artery occlusion. We conclude that GSK‐3 inhibition by SB216763 might pave the way of novel promising therapies aimed at stimulating the renewal of functional mitochondria and reducing reactive oxygen species‐mediated damage in ischemic stroke.Keywords
This publication has 49 references indexed in Scilit:
- Beyond Neuroprotection to Brain Repair: Exploring the Next Frontier in Clinical Neuroscience to Expand the Therapeutic Window for StrokeTranslational Stroke Research, 2010
- PGC-1α in aging and anti-aging interventionsBiochimica et Biophysica Acta (BBA) - General Subjects, 2009
- Mitochondrial membrane permeabilization in neuronal injuryNature Reviews Neuroscience, 2009
- Disrupted in Schizophrenia 1 Regulates Neuronal Progenitor Proliferation via Modulation of GSK3β/β-Catenin SignalingCell, 2009
- Oxidants and Ca+2 induce PGC-1α degradation through calpainArchives of Biochemistry and Biophysics, 2008
- Mitochondrial biogenesis and healthy agingExperimental Gerontology, 2008
- Mitochondria—A Nexus for Aging, Calorie Restriction, and Sirtuins?Cell, 2008
- Efficacy of small‐molecule glycogen synthase kinase‐3 inhibitors in the postnatal rat model of tau hyperphosphorylationBritish Journal of Pharmacology, 2007
- Mechanisms of impaired mitochondrial energy metabolism in acute and chronic neurodegenerative disordersJournal of Neuroscience Research, 2007
- PS1 activates PI3K thus inhibiting GSK‐3 activity and tau overphosphorylation: effects of FAD mutationsThe EMBO Journal, 2004